MARK SKINNER: Open Payments
NPI 1699860809 · DELAWARE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$973 in 67 payments from 8 companies in 2025. Trend: 2023 $698 · 2024 $587 · 2025 $973
Food & beverage: $973
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $237 |
| Otsuka America Pharmaceutical, Inc. | 11 | $215 |
| Axsome Therapeutics, Inc. | 11 | $183 |
| Lundbeck LLC | 6 | $100 |
| Vanda Pharmaceuticals Inc. | 4 | $81 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $76 |
| Teva Pharmaceuticals USA, Inc. | 3 | $67 |
| Tris Pharma Inc | 1 | $14 |
Products named: VRAYLAR, Auvelity, REXULTI, ABILIFY ASIMTUFII, FANAPT, CAPLYTA, AUSTEDO XR, ABILIFY MAINTENA.
Industry payments across OH — which companies pay providers there.
